BORONIC ACID BEARING LIPHAGANE COMPOUNDS AS INHIBITORS OF PI3K-.ALPHA. AND/OR .BETA

Compounds with unique liphagane meroterpenoid scaffold having boronic acid functionality in the skeleton are described [formula 1] together with pharmacological potential of these compounds as anticancer agents. A method of preparation and inhibiting the activity of phosphoinositide-3-kinase (PI3K-a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	VISHWAKARMA, RAM ASREY, DAR, ABID HAMID, SAXENA, AJIT KUMAR, HUSSAIN, AASHIQ, SINGH, PARVINDER PAL, SHARMA, PARDUMAN RAJ, KOLLURU, ANJANEYA ARAVIND KUMAR, QAZI, ASIF KHURSHID, NARGOTRA, AMIT, CHANAURIA, NAYAN, SAWANT, SANGHAPAL DAMODHAR, MUDUDUDDLA, RAMESH
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Compounds with unique liphagane meroterpenoid scaffold having boronic acid functionality in the skeleton are described [formula 1] together with pharmacological potential of these compounds as anticancer agents. A method of preparation and inhibiting the activity of phosphoinositide-3-kinase (PI3K-alpha and beta) has been presented. In particular, the invention describes a method of inhibiting PI3K isoforms, wherein the compounds are novel structures based on liphagane scaffold with unique boronic acid functionality. The methods and uses thereof are described herein this invention. The claimed Markush formula is: [Formular 1]. Y can be O, NH, NR, S; Representative compounds are: [Compounds A, B, C, D]